Biocon Limited

We are a global biopharmaceutical company which believes that everyone has a right to affordable quality medicines.

Powered by advanced therapy platforms, our 13,500+ employees blend heart, science and creativity to make better healthcare solutions.

Our 4 global businesses include generics, biosimilars, research services and novel biologics. They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely ‘emerging markets’ orientation.

We have leveraged India’s value advantage of unmatched scientific talent and cost-competitive manufacturing to deliver scale, speed and quality. By making medicines more easily accessible for patients across the globe, we’re working towards achieving health equity.

We are committed to providing everyone, everywhere, affordable access to a speciality portfolio of medicines.

We are steadfastly investing in developing novel therapies for diabetes, oncology and immunology. We are strengthening our global reach and economies of scale.